Calumet Reports Third Quarter 2026 Results

Calumet reported Q3 2026 net income of $273.3 million and Adjusted EBITDA of $322.0 million, up from $69.6 million a year earlier; Adjusted EBITDA with Tax Attributes was $347.2 million. Specialty Products and Solutions Adjusted EBITDA rose to $248.1 million from $80.2 million, while Montana/Renewables delivered $110.6 million with Tax Attributes. The company said it retired approximately $265 million of debt since July; results also included $113.8 million of unrealized derivative losses and $176.7 million in non-cash RIN-related items.

Analysis

The equity story is a quality-of-earnings and durability question, not simply an EBITDA beat. SPS is the main earnings engine, but management attributes the step-up partly to specialty-product scarcity; if disrupted supply normalizes, margins can mean-revert before the market has fully capitalized the debt reduction. The benefit of paying down high-coupon debt is more durable, though it does not eliminate balance-sheet sensitivity: reported adjusted EBITDA excludes meaningful non-cash and RIN-related items and is not equivalent to free cash flow. Working-capital absorption and the size/timing of cash realization from tax attributes and clean-fuel credits deserve close scrutiny.

Over the next 1–3 months, watch whether operating cash generation—not adjusted EBITDA—funds additional debt retirement, and whether specialty margins hold as supply conditions change. Montana Renewables offers upside if policy support, eligible credit monetization and execution persist; the headline tax-attribute measure is not proof of cash proceeds at face value. Over 6–18 months, MaxSAF expansion adds growth optionality but introduces schedule, cost and commissioning risk. A weaker RIN/credit regime, feedstock or product-spread reversal, outages, or renewed working-capital strain could quickly undo the equity improvement.

Consensus may over-extrapolate a scarcity-driven SPS quarter and underweight improving credit quality. A measured long is justified only as a catalyst-driven position, not a normalized-earnings valuation call; absent share-price/valuation context, avoid asserting upside magnitude.

Key Decisions for Investors

• Consider a staged, modest long in CLMT, preferably after the initial earnings reaction; add only if the next report confirms positive operating cash flow alongside continued debt retirement. Thesis breaks if cash conversion deteriorates or debt paydown stalls despite strong adjusted EBITDA.
• Track cash actually received for clean-fuel tax attributes, RIN liability movements, working capital, and SPS adjusted gross profit per barrel. Treat reported adjusted EBITDA with tax attributes as an operating indicator, not cash available for debt service.
• Keep Montana Renewables/MaxSAF as an option-like catalyst rather than underwriting the expansion today. Reassess on verified project cost, schedule, production ramp and credit monetization; cut exposure on material delays or weaker-than-expected realized credit proceeds.
• Do not chase a large post-release move without valuation and positioning context. The principal near-term downside is normalization of specialty-product scarcity; the medium-term upside is compounding interest savings if cash-funded deleveraging continues.